Skip to content

Luxusgueter Aktien News Wuxi Biologics Locations

⌚️ Hast du nur 60 Sekunden?
Wir wissen, dass Zeit kostbar ist und nicht jeder gerne lange Artikel liest, daher empfehlen wir Ihnen, sich das folgende Video anzusehen, aber lesen Sie trotzdem unseren Artikel, wenn Sie tiefergehende Informationen wünschen!

Häufig Gestellte Fragen

1How Many Employees Does Wuxi Biologics Have??

With over 10,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions.

2Who Owns Wuxi Biologics?

WuXi Biologics, A wholly owned subsidiary of WuXi AppTec.

3What Do Wuxi Biologics Do?

WuXi Biologics’ services are designed to accelerate the discovery and development process for biopharmaceutical drugs, while reducing the cost of production. WuXi Biologics offers the full spectrum of discovery services for the generation, characterisation and selection of high-potency, novel antibody therapeutics.

4When Did Wuxi Biologics Go Public?

The shares began trading on the Main Board of the Stock Exchange of Hong Kong on June 13, 2017.

5Who Owns Wuxi Pharmaceuticals?

WuXi’s founder is Dr. Ge Li, an organic chemist, who founded WuXi PharmaTech in Shanghai in December 2000.

6What Kind Of Company Is Wuxi Biologics?

WuXi Biologics is a global [Contract Research, Development and Manufacturing Organization, | CRDMO] that provides open-access, integrated technology platforms for biologics drug development.

7Is Wuxi A Chinese Company?

WuXi Biologics is China’s leading biologics medicine manufacturer. Headquartered in the city of WuXi, just under two hours from Shanghai, the company is listed on the Hong Kong stock exchange and is a global biologics services provider that offers comprehensive, integrated and highly customisable services.

8What Does Wuxi Biologics Make?

& Mission. WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics from concept to commercialization for the benefit of patients worldwide.